Piramal Pharma shares jump over 4% after Q2 net profit jumps 3-fold; Should you Buy, Sell, Hold?

Shares of Piramal Pharma jumps over 4% to intra-day high of Rs 230 on NSE today after the company reported a strong financial performance for the second quarter of FY25. The company’s net profit surged by an impressive 350% year-on-year, reaching Rs 22.59 crore, compared to Rs 5.02 crore in Q2 FY24.

Revenue and EBITDA Growth

Revenue from operations grew by 17.3%, totaling Rs 2,241.75 crore, up from Rs 1,911.38 crore in the same quarter last year. Piramal Pharma’s earnings before interest, taxes, depreciation, and amortization (EBITDA) rose 29%, increasing to Rs 341.61 crore from Rs 265.64 crore. The EBITDA margin also improved to 15.2% from 13.9% year-on-year.

Key Drivers of Growth

The robust growth in EBITDA was driven by operating leverage, cost optimization initiatives, and an enhanced revenue mix. Chairperson Nandini Piramal noted, “We continue our momentum of delivering healthy revenue growth, accompanied by year-on-year EBITDA margin expansion.”

Also Read Tech Mahindra shares gain over 3% after company beats Q2 estimate; Should you Buy, Sell, or Hold? Wipro shares zoom over 5% after Q2 betters estimates; is it the right time to buy? Anil Ambani led Reliance Power shares plunge 4% ahead of board meeting Reliance Power shares hit 5% upper circuit for 10th straight day; gains 48% in 1 month

Also ReadPiramal Pharma Share Price Today Live Updates, 24 Oct, 2024: Piramal Pharma on the radar

She attributed this success primarily to the company’s Contract Development and Manufacturing Organization (CDMO) business, which has seen a strong uptick in innovation-related projects and on-patent commercial revenues.

Expansion Plans

To maintain its growth trajectory and meet rising demand for sterile fill-finish capabilities, Piramal Pharma has announced an $80-million expansion plan for its Lexington facility.

Also ReadPiramal Pharma Q2 Results: Profit jumps 350% at Rs 22.59 crore, revenue up 17.3% YoY on growth in CDMO business

This expansion is expected to be completed by the end of fiscal 2027, according to Nandini Piramal. The company aims to further enhance its capabilities to capitalize on future growth opportunities.

Stock Performance in Last One Year

Piramal Pharma shares have delivered positive returns across various time frames. Over the last three months, the stock has shown a positive return of 39.58%, indicating short-term growth. In the last six months,

 » Read More

Related Articles

Highest bank FD rates in July: Which banks offer best fixed deposit interest rates to senior citizens?

It seems that the high-interest-rate regime, which prevailed for almost three years, has come to an end in the wake of the RBI slashing the repo rate by 100 basis points (bps) this year. However, there are some private sector banks that are still offering attractive interest rates on their fixed deposits (FDs) for senior

IndiGo Q1 FY26: Profit drops 20%, while passenger traffic and revenue grow- Key highlights

IndiGo airline operator InterGlobe Aviation reported a drop in first-quarter profit on Wednesday. The company posted a profit of Rs 2,176.3 crore for the April–June period, down 20.25 per cent from Rs 2,728.8 crore a year ago, and down 29 per cent sequentially from Rs 3,067.5 crore in Q4 FY25. Revenue from operations stood at

Markets end flat after rangebound session: Nifty manages to close above 24,800 – 4 key highlights

It was a quiet yet resilient day on Dalal Street as benchmark indices ended the session on a flat note with a slight upward tilt. The Sensex settled at 81,465.28, up 0.16%, while the Nifty wrapped up the day at 24,855.05, also gaining 0.18%. Meanwhile, the Nifty Bank ended the day at 56,150, down 0.13%.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Stay Connected

0FansLike
0FollowersFollow
0SubscribersSubscribe
- Advertisement -

Latest Articles

Highest bank FD rates in July: Which banks offer best fixed deposit interest rates to senior citizens?

It seems that the high-interest-rate regime, which prevailed for almost three years, has come to an end in the wake of the RBI slashing the repo rate by 100 basis points (bps) this year. However, there are some private sector banks that are still offering attractive interest rates on their fixed deposits (FDs) for senior

IndiGo Q1 FY26: Profit drops 20%, while passenger traffic and revenue grow- Key highlights

IndiGo airline operator InterGlobe Aviation reported a drop in first-quarter profit on Wednesday. The company posted a profit of Rs 2,176.3 crore for the April–June period, down 20.25 per cent from Rs 2,728.8 crore a year ago, and down 29 per cent sequentially from Rs 3,067.5 crore in Q4 FY25. Revenue from operations stood at

Markets end flat after rangebound session: Nifty manages to close above 24,800 – 4 key highlights

It was a quiet yet resilient day on Dalal Street as benchmark indices ended the session on a flat note with a slight upward tilt. The Sensex settled at 81,465.28, up 0.16%, while the Nifty wrapped up the day at 24,855.05, also gaining 0.18%. Meanwhile, the Nifty Bank ended the day at 56,150, down 0.13%.

Income tax refund in 4 hours: Taxpayers report ‘fastest-ever ITR processing’

It seems that long waits and weeks of uncertainty after filing income tax returns (ITRs) have become the thing of the past, at least for many individual taxpayers. This year, many taxpayers are receiving their income tax refunds within mere hours of e-filing their income tax returns. This is a major shift from past years

MMRDA deposits Rs 560.21 crore in Bombay HC over metro arbitration dispute with Reliance Infra JV

The Mumbai Metropolitan Region Development Authority (MMRDA) has deposited Rs 560.21 crore with the Registry of the Bombay High Court in an arbitration matter that involved Mumbai Metro One Private Limited (MMOPL).  MMOPL, a subsidiary of Anil Ambani-promoted Reliance Infrastructure (R-Infra), is a joint venture between the company and MMRDA. While Reliance Infra holds 74